A screening program to test and treat for Helicobacter pylori infection: Cost-utility analysis by age, sex and ethnicity

scientific article

A screening program to test and treat for Helicobacter pylori infection: Cost-utility analysis by age, sex and ethnicity is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1186/S12879-017-2259-2
P8608Fatcat IDrelease_7zawi3evm5gotmfah46vkrwlyq
P932PMC publication ID5319166
P698PubMed publication ID28219322

P50authorAndrea TengQ57902327
Nick WilsonQ90100179
Tony BlakelyQ57449785
Nisha NairQ91141347
Giorgi KvizhinadzeQ91141350
Melissa McLeodQ91141353
P2860cites workIllustrating Economic Evaluation of Diagnostic Technologies: Comparing Helicobacter pylori Screening Strategies in Prevention of Gastric Cancer in CanadaQ59404619
Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancerQ77932028
Comparison of a stool antigen test and serology for the diagnosis of Helicobacter pylori infection in mass surveyQ83504231
Helicobacter pylori eradication for the prevention of gastric neoplasiaQ24186365
Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infectionQ24632307
Canadian Helicobacter Study Group Consensus Conference: Update on the management of Helicobacter pylori--an evidence-based evaluation of six topics relevant to clinical outcomes in patients evaluated for H pylori infectionQ28214073
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.Q30485861
The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trialQ30677538
Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trialsQ33636554
Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroupsQ33792622
The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation modelQ35112530
A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trialQ36339226
Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial resultsQ37003878
Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infectionQ37605214
Increasing primary antibiotic resistance and ethnic differences in eradication rates of Helicobacter pylori infection in New Zealand--a new look at an old enemyQ38155771
The fight against gastric cancer - the IARC Working Group reportQ38273500
The contribution of Helicobacter pylori to excess gastric cancer in Indigenous and Pacific men: a birth cohort estimateQ40448559
Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trialsQ41018165
Trends in Helicobacter pylori infection among Māori, Pacific, and European Birth cohorts in New ZealandQ41658285
Helicobacter pylori test-and-treat program can be cost-effective to prevent gastric cancer in Taiwanese adults: referred to the nationwide reimbursement databaseQ41670325
Helicobacter pylori and gastric cancer: what are the benefits of screening only for the CagA phenotype of H. pylori?Q41675055
Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in ChineseQ43777110
Global burden of gastric cancer attributable to Helicobacter pyloriQ44946941
Social inequalities or inequities in cancer incidence? Repeated census-cancer cohort studies, New Zealand 1981-1986 to 2001-2004Q49109423
Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer.Q51101883
Whom should we "test and treat" for Helicobacter pylori?Q52839621
P433issue1
P921main subjectHelicobacter pyloriQ180556
Helicobacter pylori infectious diseaseQ4497153
P304page(s)156
P577publication date2017-02-20
P1433published inBMC Infectious DiseasesQ15759919
P1476titleA screening program to test and treat for Helicobacter pylori infection: Cost-utility analysis by age, sex and ethnicity
P478volume17

Reverse relations

cites work (P2860)
Q90223477Assessing the value of screening tools: reviewing the challenges and opportunities of cost-effectiveness analysis
Q90595136Cost-effectiveness of Helicobacter pylori screening followed by eradication treatment for employees in Japan

Search more.